Trials / Terminated
TerminatedNCT02305056
Study of Tumor Metabolism by Isotopic Tagging in Patients With High-grade Glioma (CARBONOMIC)
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- University Hospital, Grenoble · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to follow tumoral proteins metabolism by in vivo no radioactive isotopic tagging (carbon 13 and nitrogen 15).
Detailed description
The project aims to study protein turnover in glioblastoma using mass spectrometry after 13C-valine incorporation. This will allow to identify proteins in circulation secreted by tumor which could be diagnostic and pronostic biomarkers in patients With High-grade Glioma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | C13 N15 Valine | C13 N15 Valine administration |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2018-01-30
- Completion
- 2018-01-30
- First posted
- 2014-12-02
- Last updated
- 2018-05-09
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02305056. Inclusion in this directory is not an endorsement.